Updated: FDA will reclassify at least a dozen peptides, teeing up potential telehealth win
更新：美国食品药品监督管理局将把至少十几种肽类物质重新归类，或为远程医疗带来利好

The FDA threw its support behind a dozen peptides, announcing plans to reclassify them, likely presenting a huge money-making opportunity for what’s been a largely opaque market to-date.
美国食品药品监督管理局支持了十余种肽类物质，并宣布计划将其重新分类，这一举措很可能为迄今基本不透明的市场带来巨大的盈利机会。